Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
about
Acid suppressive drugs and gastric cancer: a meta-analysis of observational studiesPlasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinomaAutocrine growth factors and solid tumor malignancy.Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia.Personal review: is profound acid inhibition safe?Mechanism of gastric mucosal proliferation induced by gastrin.Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Review article: gastrin and colorectal cancer.Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in ratsPostprandial hypergastrinaemia in patients with colorectal cancer.Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies.Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections.Therapeutic potential of growth factors and their antagonists.Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemiaLong-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression.Helicobacter pylori infection and colorectal carcinoma: is there a causal association?Atrophic gastritis and the risk of incident colorectal cancer.The consequences of hypergastrinemia.A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.Neuropeptide growth factors and cancer.The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth.Gastrin, gastrin receptors and colorectal carcinoma.Association of helicobacter pylori infection and colon cancer.Identification of progastrin derived peptides in colorectal carcinoma extracts.Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM.
P2860
Q27025101-ABD200C2-1378-4EE3-8527-3DCA78EE885CQ28345115-39C5C505-A8A5-4CE2-9043-35929F140455Q33559452-C7BACF67-8B8E-4991-BA79-D403D1DA77A5Q33771052-9D569837-5D2C-4104-8D2A-CF5F9917D4F2Q33815745-70402AA9-0531-4B0F-81F5-DCB3E4DF0817Q33888030-06DDE395-B5E0-4893-B5F7-1455E0BC44B5Q33940198-C18019F2-045F-4925-B487-0E11D9288047Q34049799-DA0658CC-8FA7-4DA7-8970-D7FF05596A88Q34377608-31CBB5C6-B3C4-4216-81A0-A916904835F4Q34394773-02B13F3B-7AE8-4766-BA7C-CF3DF1926527Q34463547-372F547E-2639-4F70-8A8F-D9260A706D92Q35194532-DC4A9FAF-3D9C-4AF5-AAF0-48B85A2D35E2Q35242622-888177AF-C58E-445A-8FC0-8D062F015856Q35841014-F072FB40-AD2B-4E1C-B4C6-55975A3D7591Q36190380-82D95B5B-DC9C-4AB9-849E-FF4ECBF46620Q36381202-03A0CDD8-5856-4A24-A5AF-85A45CFEE126Q36434231-BDEAA005-94F9-42FB-BDBC-B8D904F3BD5BQ36987482-2FD9DFCB-2847-4D3F-B52B-048DB2C83555Q37524960-A58F8D6B-044F-41C0-99D3-F6BE41A02B3AQ37664018-2EB5F486-6AE8-41E3-A508-FA26F470206CQ40548301-B8ED52AC-75DB-4F8E-B88A-DB83272D35D5Q41998447-64810C11-5BBC-471A-A36B-53C2A2191569Q42204133-1DD70681-DBE7-4D44-BDE5-880FD76C82B3Q43212765-1A14908B-049D-42FB-BE64-80CBBCEEF6E0Q53412538-0D37EDB6-4E12-46B9-BE11-67ECAF8F68D9
P2860
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@en
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@nl
type
label
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@en
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@nl
prefLabel
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@en
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@nl
P2093
P356
P1476
Elevated gastrin levels in patients with colon cancer or adenomatous polyps.
@en
P2093
P2888
P304
P356
10.1007/BF01536047
P577
1989-02-01T00:00:00Z